Antidepressant: Infarmed orders withdrawal of several sertraline batches from the market

Monday, 26 January 2026RSS
Antidepressant: Infarmed orders withdrawal of several sertraline batches from the market

An impurity above the acceptable limit was detected, the National Institute of Pharmacy and Medicines clarifies in an alert published on its website.

Context & Explainers

Infarmed (Autoridade Nacional do Medicamento e Produtos de Saúde) is Portugal’s national regulator for medicines and health products that approves drugs, monitors safety and enforces rules on pricing and reimbursement. In 2025 it approved 928 new medicines — 79% were generics, 38 were designated essential and 236 were national products — which affects which medicines are available and how much they cost at pharmacies.

View full article on RTP Notícias

RSS source